Patents by Inventor Barry Barton

Barry Barton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10292364
    Abstract: A implant tracking system for allowing the location of an animal to be tracked from an implanted device that is not readily removable includes an implant member having an internal positioning component that is connected to an internal rechargeable power component and a wearable charger implement that includes an inductive charging band, a wire charging port, an internal charger battery, and an attachment mechanism. In one instance, the positioning component is a satellite positioning system receiver. In use, it is contemplated that the implant member is implanted under the skin of a pet or other animal whose location is desired to be tracked while the wearable charger can be removably positioned on the pet in order to wirelessly recharge the power component of the implant member through inductive charging.
    Type: Grant
    Filed: August 9, 2016
    Date of Patent: May 21, 2019
    Inventors: Barry Barton, Dana Barton
  • Publication number: 20180042202
    Abstract: A implant tracking system for allowing the location of an animal to be tracked from an implanted device that is not readily removable includes an implant member having an internal positioning component that is connected to an internal rechargeable power component and a wearable charger implement that includes an inductive charging band, a wire charging port, an internal charger battery, and an attachment mechanism. In one instance, the positioning component is a satellite positioning system receiver. In use, it is contemplated that the implant member is implanted under the skin of a pet or other animal whose location is desired to be tracked while the wearable charger can be removably positioned on the pet in order to wirelessly recharge the power component of the implant member through inductive charging.
    Type: Application
    Filed: August 9, 2016
    Publication date: February 15, 2018
    Inventors: Barry Barton, Dana Barton
  • Patent number: 7622302
    Abstract: New processes for improving the manufacture of clavams e.g. clavulanic acid. Novel DNA sequences and new microorganisms capable of producing increased amounts of clavulanic acid are also disclosed.
    Type: Grant
    Filed: April 13, 2004
    Date of Patent: November 24, 2009
    Assignees: Glaxo Group Limited, The Governors of the University of Alberta
    Inventors: Barry Barton, Alison Michelle Griffin, Susan Jensen, Annie Wong
  • Patent number: 7344869
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: March 18, 2008
    Assignees: SmithKline Beecham p.l.c., The Governors of the University of Alberta
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Publication number: 20070298470
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: October 8, 2004
    Publication date: December 27, 2007
    Inventors: Cecilia Anders, Barry Barton, John Griffin, Susan Jensen, Roy Mosher, Ashish Paradkar
  • Patent number: 6936458
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: August 30, 2005
    Assignees: SmithKline Beecham p.l.c., The Governors of the University of Alberta
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Publication number: 20050181489
    Abstract: A process for the synthesis of clavam compounds, in particular clavulanic acid using ?-lactam synthetase polypeptides and ?-lactam synthetase polynucleotides.
    Type: Application
    Filed: March 16, 2005
    Publication date: August 18, 2005
    Inventors: Barry Barton, Heather McNaughton
  • Patent number: 6905849
    Abstract: The present invention relates to a new process for the synthesis of clavam compounds, in particular clavulanic acid. In one aspect, the invention relates to Streptomyces clavuligerus ?-lactam synthetase polypeptide sand Streptomyces clavuligerus ?-lactam synthetase polynucleotides, recombinant materials thereof and methods for their production. In another aspect, the invention relates to methods for using such polypeptides and polynucleotides.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: June 14, 2005
    Assignee: SmithKline Beecham plc
    Inventors: Barry Barton, Heather Jane McNaughton, Christopher Joseph Schofield, Jan Edward Thirkettle
  • Publication number: 20050079498
    Abstract: The invention relates to improvements in and relating to the biosynthesis of clavam compounds in particular clavulanic acid. Disclosed are new polynucleotides involved in the biosynthesis of clavulanic acid. Also disclosed are uses of said polynucleotides in improving clavulanic acid production.
    Type: Application
    Filed: November 6, 2002
    Publication date: April 14, 2005
    Inventors: Cecilia Anders, Barry Barton, Alison Griffin, Susan Jensen
  • Publication number: 20040081960
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: February 24, 2003
    Publication date: April 29, 2004
    Applicants: SmithKline Beecham p.l.c., The Governors of the University of Alberta
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Publication number: 20030166175
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: November 7, 2002
    Publication date: September 4, 2003
    Applicant: SmithKline Beecham plc
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henrey Mosher, Ashish Sudhakar Paradkar
  • Publication number: 20030124690
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: November 7, 2002
    Publication date: July 3, 2003
    Applicant: SmithKline Beecham plc
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Publication number: 20030109694
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: November 6, 2002
    Publication date: June 12, 2003
    Applicant: SmithKline Beecham plc
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henry Mosher, Ashish Sudhakar Paradkar
  • Publication number: 20030022321
    Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid.
    Type: Application
    Filed: February 8, 2002
    Publication date: January 30, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Cecilia Anders, Barry Barton, John Patrick Griffin, Susan Jensen, Roy Henrey Mosher, Ashish Sudhakar Paradkar
  • Patent number: 6361982
    Abstract: DNA comprising a regulatory gene for clavulanic acid biosynthesis. DNA is no greater than 7 kb in length and has the configuration of restriction sites shown in FIG. 1 or a fragment thereof. Use of DNA in a method for producing clavulanic acid in a host.
    Type: Grant
    Filed: August 31, 1995
    Date of Patent: March 26, 2002
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Nicola Jane Walters, Barry Barton, Alison Jane Earl